EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 03 Mejju 2024. Database contains 4917 unique substances/entries.

Filter the list

Juri 1 - 100 ta' 4,917 riżultati.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC	EU_BA Directive 2000/54/EC
ε-caprolactam	203-313-2	105-60-2	Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2			Details
α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)] PC-709	413-420-8	144736-29-8	Skin Corr. 1B; Skin Sens. 1			Details
α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)	639-478-6	182635-99-0	Acute Tox. 4; Skin Corr. 1B			Details
α-cypermethrin (ISO); racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; (S)-α-cyano-3-phenoxybenzyl(1R, 3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate	614-054-3	67375-30-8	Acute Tox. 3; STOT RE 2; STOT SE 3			Details
α-chlorotoluene; benzyl chloride	202-853-6	100-44-7	Carc. 1B; Acute Tox. 3; Acute Tox. 4; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1			Details
α-bromotoluene; benzyl bromide	202-847-3	100-39-0	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2			Details
α-[3-(1-oxoprop-2-enyl)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane) ACRYLOXYPROPYL DIMETHOXYSILOXY TERMINATED POLYDIMETHYL SILOXANE	415-290-8	193159-06-7	Skin Sens. 1			Details
α,α-Bis[4-(dimethylamino)phenyl]-4 (phenylamino)naphthalene-1-methanol; C.I. Solvent Blue 4	229-851-8	6786-83-0		C Carcinogenic (article 57a)		Details
α, α-dimethylbenzyl hydroperoxide; cumene hydroperoxide	201-254-7	80-15-9	Org. Perox. E; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Skin Corr. 1B			Details
α, α-dichlorotoluene; benzylidene chloride; benzal chloride	202-709-2	98-87-3	Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1			Details
α, α, α-trifluorotoluene; benzotrifluoride	202-635-0	98-08-8	Flam. Liq. 2			Details
α, α, α-trichlorotoluene; benzotrichloride	202-634-5	98-07-7	Carc. 1B; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1			Details
α, α, α,4-tetrachlorotoluene; p-chlorobenzotrichloride	226-009-1	5216-25-1	Carc. 1B; Repr. 2; STOT RE 1; Acute Tox. 4; STOT SE 3; Skin Irrit. 2			Details
zoxamide (ISO); (RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide	605-037-1	156052-68-5	Skin Sens. 1			Details
zirconium powder (pyrophoric);zirconium powder, dry (non pyrophoric)	231-176-9	7440-67-7	Self-heat. 1			Details
zirconium powder (pyrophoric);zirconium powder, dry (non pyrophoric)	231-176-9	7440-67-7	Water-react. 1; Pyr. Sol. 1			Details
Zirconia Aluminosilicate Refractory Ceramic Fibres	936-037-2	-		C Carcinogenic (article 57a)		Details
ziram (ISO); zinc bis dimethyldithiocarbamate	205-288-3	137-30-4	Acute Tox. 2; Acute Tox. 4; STOT RE 2; STOT SE 3; Eye Dam. 1; Skin Sens. 1			Details
zineb (ISO); zinc ethylenebis(dithiocarbamate) (polymeric)	235-180-1	12122-67-7	STOT SE 3; Skin Sens. 1			Details
zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate	417-130-2	1379689-21-0	Eye Dam. 1			Details
zinc sulphate (hydrous) (mono-, hexa-and hepta hydrate)	616-096-8	7446-19-7	Acute Tox. 4; Eye Dam. 1			Details
zinc sulphate (anhydrous)	231-793-3	7733-02-0	Acute Tox. 4; Eye Dam. 1			Details
zinc powder — zinc dust (pyrophoric)	231-175-3	7440-66-6	Water-react. 1; Pyr. Sol. 1			Details
zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex	425-240-7	-	Eye Dam. 1			Details
zinc chromates including zinc potassium chromate show/hide Chromic acid, potassium zinc salt EC / List no: 255-252-6 \| CAS no: 41189-36-0 C.I. Pigment Yellow 36 EC / List no: 609-398-6 \| CAS no: 37300-23-5 Zinc dichromate EC / List no: 237-843-0 \| CAS no: 14018-95-2 Zinc chromate EC / List no: 236-878-9 \| CAS no: 13530-65-9 Potassium hydroxyoctaoxodizincatedichromate(1-) EC / List no: 234-329-8 \| CAS no: 11103-86-9 Pentazinc chromate octahydroxide EC / List no: 256-418-0 \| CAS no: 49663-84-5	-	-	Carc. 1A; Acute Tox. 4; Skin Sens. 1			Details
zinc chloride	231-592-0	7646-85-7	Acute Tox. 4; Skin Corr. 1B			Details
zinc bis(diethyldithiocarbamate)	238-270-9	14324-55-1	Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1			Details
zinc bis(dibutyldithiocarbamate)	205-232-8	136-23-2	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1			Details
zinc 2-hydroxy-5-C13-18 alkylbenzoate Z-6	402-280-3	149144-82-1	Eye Irrit. 2; Skin Irrit. 2			Details
Yersinia spp.	-	-			B Bacteria and similar species	Details
Yersinia pseudotuberculosis	-	-			B Bacteria and similar species	Details
Yersinia pestis	-	-			B Bacteria and similar species	Details
Yersinia enterocolitica	-	-			B Bacteria and similar species	Details
Yellow fever	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Yatapox virus	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
xylylcarb (ISO); 3,4-dimethylphenyl N-methylcarbamate; 3,4-xylyl methylcarbamate; MPMC	219-364-9	2425-10-7	Acute Tox. 4			Details
xylidines with the exception of those specified elsewhere in this Annex; dimethyl anilines with the exception of those specified elsewhere in this Annex	215-091-4	1300-73-8	Acute Tox. 3; STOT RE 2			Details
xylenol	215-089-3	1300-71-6	Acute Tox. 3; Skin Corr. 1B			Details
xylene	215-535-7	1330-20-7	Flam. Liq. 3; Acute Tox. 4; Skin Irrit. 2			Details
XMC; 3,5-xylyl methylcarbamate	607-955-8	2655-14-3	Acute Tox. 4			Details
Wuchereria bancrofti	-	-			P Parasites	Details
Whitepox virus	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
white phosphorus	601-810-2	12185-10-3	Pyr. Sol. 1; Acute Tox. 2; Skin Corr. 1A			Details
Western equine encephalomyelitis	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
West Nile fever virus	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Wesselsbron virus	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Waste solids, coal-tar pitch coking; Coal Tar Solids Residue [The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.] The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.	295-549-8	92062-34-5	Carc. 1B			Details
warfarin (ISO); 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one;	201-377-6	81-81-2	Repr. 1A; Acute Tox. 1; Acute Tox. 2; STOT RE 1			Details
vinyl chloride; chloroethylene	200-831-0	75-01-4	Press. Gas; Flam. Gas 1; Carc. 1A			Details
vinyl acetate	203-545-4	108-05-4	Flam. Liq. 2; Carc. 2; Acute Tox. 4; STOT SE 3			Details
vinclozolin (ISO); N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione	256-599-6	50471-44-8	Carc. 2; Repr. 1B; Skin Sens. 1			Details
Vibrio spp.	-	-			B Bacteria and similar species	Details
Vibrio parahaemolyticus	-	-			B Bacteria and similar species	Details
Vibrio cholerae (including El Tor)	-	-			B Bacteria and similar species	Details
Vesicular stomatitis virus	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
vernolate (ISO); S-propyl dipropylthiocarbamate	217-681-7	1929-77-7	Acute Tox. 4			Details
Venezuelan equine encephalomyelitis	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Variola (major and minor) virus	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Variant Creutzfeldt-Jakob disease	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
vanadyl pyrophosphate BTN; VPO CATALYST	406-260-5	58834-75-6	Eye Irrit. 2; Skin Sens. 1			Details
vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped	424-390-0	93280-40-1	Acute Tox. 4; STOT RE 2; Eye Dam. 1			Details
vamidothion (ISO); O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate	218-894-8	2275-23-2	Acute Tox. 3; Acute Tox. 4			Details
valinamide D,L-VALINEAMIDE	402-840-7	20108-78-5	Repr. 2; Eye Irrit. 2; Skin Sens. 1			Details
valeric acid	203-677-2	109-52-4	Skin Corr. 1B			Details
Vaccinia virus	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine ITC 826 CONCENTRATE	422-720-8	166242-53-1	Carc. 2; Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1			Details
urethane (INN); ethyl carbamate	200-123-1	51-79-6	Carc. 1B			Details
uranium compounds with the exception of those specified elsewhere in this Annex show/hide Nickel triuranium decaoxide EC / List no: 239-876-6 \| CAS no: 15780-33-3 Triuranium octaoxide EC / List no: 215-702-4 \| CAS no: 1344-59-8 Uranium trifluoride EC / List no: 237-404-3 \| CAS no: 13775-06-9 Calcium diuranium heptaoxide EC / List no: 237-428-4 \| CAS no: 13780-21-7 Lead uranate pigment EC / List no: 287-565-9 \| CAS no: 85536-79-4 Tetrakis(pentane-2,4-dionato-O,O')uranium EC / List no: 265-498-6 \| CAS no: 65137-03-3 Bis(acetato-O)dioxouranium EC / List no: 208-767-5 \| CAS no: 541-09-3 Uranium hydride EC / List no: 257-346-2 \| CAS no: 51680-55-8 Dioxobis(pentane-2,4-dionato-O,O')uranium EC / List no: 241-951-3 \| CAS no: 18039-69-5 Dipotassium uranyl bis(sulphate), of uranium depleted in uranium-235 EC / List no: 262-284-4 \| CAS no: 60542-74-7 Dipotassium heptaoxodiuranate EC / List no: 232-217-3 \| CAS no: 7790-63-8 Barium uranium oxide EC / List no: - \| CAS no: 10380-31-1 Triuranium tetraphosphide EC / List no: 234-871-5 \| CAS no: 12037-84-2 Titanate(4-), oxobis[phosphato(3-)]-, barium (1:2), uranium-doped EC / List no: 309-550-9 \| CAS no: 100403-10-9 Uranium tetrachloride EC / List no: 233-057-7 \| CAS no: 10026-10-5 Tetraammonium uranyl tricarbonate, of uranium depleted in uranium-235 EC / List no: 241-988-5 \| CAS no: 18077-77-5 [oxalato(2-)-O,O']dioxouranium EC / List no: 217-986-5 \| CAS no: 2031-89-2 Difluorodioxouranium EC / List no: 236-898-8 \| CAS no: 13536-84-0 Uranium tetrabromide EC / List no: 236-734-5 \| CAS no: 13470-20-7 Uranium carbide (UC) EC / List no: - \| CAS no: 12070-09-6 Nasturan EC / List no: 690-098-7 \| CAS no: 1317-99-3 Magnesium diuranium heptaoxide EC / List no: 236-982-4 \| CAS no: 13568-61-1 Bis(formato-O)dioxouranium EC / List no: 241-063-6 \| CAS no: 16984-59-1 Uranium trioxide EC / List no: 215-701-9 \| CAS no: 1344-58-7 polysilicate EC / List no: - \| CAS no: 12427-14-4 Uranium tetraiodide EC / List no: 236-735-0 \| CAS no: 13470-22-9 Calcines, uranium ore-conc. Calcined precipitates of ammonium, magnesium or sodium uranates obtained from natural uranium ores. EC / List no: 297-819-0 \| CAS no: 93763-02-1 Nitric acid, uranium(6+) salt EC / List no: - \| CAS no: 20820-60-4 Uranyl acetate-2H2O EC / List no: 629-550-5 \| CAS no: 6159-44-0 Uranium dioxideperoxide EC / List no: 234-852-1 \| CAS no: 12036-71-4 Bis(nitrato-O)dioxouranium EC / List no: 233-266-3 \| CAS no: 10102-06-4 Dioxo[sulphato(2-)-O]uranium EC / List no: 215-240-3 \| CAS no: 1314-64-3 Uranium fluoride (U2F9) EC / List no: - \| CAS no: 12134-48-4 Uranium pentafluoride EC / List no: 237-405-9 \| CAS no: 13775-07-0 Uranium EC / List no: 231-170-6 \| CAS no: 7440-61-1 Uranium nitrate EC / List no: - \| CAS no: 13826-82-9 Uranium diselenide EC / List no: 235-245-4 \| CAS no: 12138-21-5 Uranium tetraboride EC / List no: 234-520-6 \| CAS no: 12007-84-0 Oxobis(pentane-2,4-dionato-O,O')uranium EC / List no: 254-311-3 \| CAS no: 39136-40-8 Uranium diboride EC / List no: 234-508-0 \| CAS no: 12007-36-2 Hydrogen dioxo[phosphato(3-)-O,O']uranate(1-) EC / List no: 242-306-9 \| CAS no: 18433-48-2 Uranate(2-), tetrakis(acetato-O)-dioxo-, magnesium (1:1), (OC-6-11)- EC / List no: - \| CAS no: 66735-86-2 Zinc bis(acetato-O)dioxouranate EC / List no: 233-390-8 \| CAS no: 10138-94-0 Bis(2-ethylhexanoato-O)dioxouranium EC / List no: 267-849-9 \| CAS no: 67939-77-9 Uranium hexafluoride EC / List no: 232-028-6 \| CAS no: 7783-81-5 Nitric acid, uranium salt EC / List no: - \| CAS no: 15905-86-9 Uranium disilicide EC / List no: 234-906-4 \| CAS no: 12039-85-9 Uranium nitride EC / List no: - \| CAS no: 12058-37-6 Uranium hydride (UH3) EC / List no: - \| CAS no: 13598-56-6 Disodium uranium tetraoxide EC / List no: 236-846-4 \| CAS no: 13510-99-1 Sodium uranyl triacetate, of uranium depleted in uranium-235 EC / List no: 241-714-4 \| CAS no: 17712-38-8 Uranium disulphide EC / List no: 234-884-6 \| CAS no: 12039-14-4 Magnesium uranium(4+) hexaacetate EC / List no: 243-905-8 \| CAS no: 20596-93-4 Diammonium diuranium heptaoxide EC / List no: 231-986-2 \| CAS no: 7783-22-4 Nickel uranyl tetraacetate, of uranium depleted in uranium-235 EC / List no: 275-994-4 \| CAS no: 71767-12-9 Sodium tris(benzeneacetato-O)dioxouranate(1-) EC / List no: 309-040-6 \| CAS no: 99800-13-2 Uranium ditelluride EC / List no: 235-249-6 \| CAS no: 12138-37-3 Acetic acid, uranium(4+) zinc salt EC / List no: 243-904-2 \| CAS no: 20596-91-2 Resin acids and Rosin acids, uranyl salts EC / List no: 273-325-0 \| CAS no: 68956-97-8 Uranium triiodide EC / List no: 237-406-4 \| CAS no: 13775-18-3 Uranium dioxide EC / List no: 215-700-3 \| CAS no: 1344-57-6 Disodium heptaoxodiuranate, of uranium depleted in uranium-235 EC / List no: 237-286-3 \| CAS no: 13721-34-1 Dichlorodioxouranium EC / List no: 232-246-1 \| CAS no: 7791-26-6 Uranium carbide (UC2) EC / List no: - \| CAS no: 12071-33-9 Bis(nitrato-O,O')dioxouranium EC / List no: 253-053-9 \| CAS no: 36478-76-9 Zinc tetrakis(acetato-O)dioxouranate EC / List no: 251-762-8 \| CAS no: 33959-50-1 Uranium tetrafluoride EC / List no: 233-170-1 \| CAS no: 10049-14-6	-	-	Acute Tox. 2; STOT RE 2			Details
uranium	231-170-6	7440-61-1	Acute Tox. 2; STOT RE 2			Details
turpentine, oil Any of the volatile predominately terpenic fractions or distillates resulting from the solvent extraction of, gum collection from, or pulping of softwoods. Composed primarily of the C10H16 terpene hydrocarbons: α-pinene, β-pinene, limonene, 3-carene, camphene. May contain other acyclic, monocyclic, or bicyclic terpenes, oxygenated terpenes, and anethole. Exact composition varies with refining methods and the age, location, and species of the softwood source.	232-350-7	8006-64-2	Flam. Liq. 3; Acute Tox. 4; Asp. Tox. 1; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1			Details
trypsin	232-650-8	9002-07-7	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1			Details
Trypanosoma cruzi	-	-			P Parasites	Details
Trypanosoma brucei rhodesiense	-	-			P Parasites	Details
Trypanosoma brucei gambiense	-	-			P Parasites	Details
Trypanosoma brucei brucei	-	-			P Parasites	Details
troclosene sodium, dihydrate	610-700-3	51580-86-0	Acute Tox. 4; Eye Irrit. 2; STOT SE 3			Details
troclosene sodium	220-767-7	2893-78-9	Ox. Sol. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3			Details
troclosene potassium	218-828-8	2244-21-5	Ox. Sol. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3			Details
trizinc diphosphide; zinc phosphide	215-244-5	1314-84-7	Water-react. 1; Acute Tox. 2			Details
trixylyl phosphate	246-677-8	25155-23-1	Repr. 1B	R Toxic for reproduction (article 57c)		Details
tritosulfuron (ISO) (containing ≤0,02 % AMTT); 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)	604-291-0	142469-14-5	Skin Sens. 1			Details
triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol	-	138182-18-0	Repr. 2; STOT RE 2			Details
trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) REACTIVE BLUE 245	407-580-8	130201-51-3	Eye Dam. 1			Details
Trisodium orthoborate	238-253-6	14312-40-4		R Toxic for reproduction (article 57c)		Details
trisodium nitrilotriacetate	225-768-6	5064-31-3	Carc. 2; Acute Tox. 4; Eye Irrit. 2			Details
trisodium N-(3-propionato)-l-aspartate	422-090-4	172737-80-3	Eye Dam. 1			Details
trisodium N, N-bis(carboxymethyl)-β-alanine TRILON(R) ES 9851	414-070-9	129050-62-0	Skin Corr. 1B			Details
trisodium N, N-bis(carboxymethyl)-3-amino-2-hydroxypropionate TRILON(R) ES 9910	414-130-4	119710-96-2	Acute Tox. 4			Details
trisodium hexafluoroaluminate(cryolite)	239-148-8	15096-52-3	STOT RE 1; Acute Tox. 4			Details
trisodium hexafluoroaluminate	237-410-6	13775-53-6	STOT RE 1; Acute Tox. 4			Details
trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III) RED JB 747	418-220-4	-	Skin Sens. 1			Details
trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-) BI 3277; NOIR CORSE SANODAL H3LW CONC.; SANODAL DEEP BLACK H-3LW CONC.; SANODAL TIEFSCHWARZ H-3LW; SANODAL TIEFSCHWARZ H-3LW KONZ.	400-810-8	106084-79-1	Muta. 2			Details
trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-) ACID BLUE 349; AZO-METALCOMPLEX-BLUE AP 1149; BLEU ACIDE 349; C.I. ACID BLUE 349; SELLASET BLEU H; SELLASET BLUE H	402-870-0	93952-24-0	Eye Dam. 1			Details
trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato2-naphthylazo)-biphenyl 1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II) SOLAMINLICHTBLAU VGRL 133	413-590-3	164058-22-4	Carc. 1B			Details
trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4, N29, N30, N31, N32-sulfonylamino)benzoato(5-)]cuprate(II) where a =1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25 TURQUOISE 10 40 518	411-430-7	-	Eye Dam. 1; Skin Sens. 1			Details
trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O, O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O, O,N]chromate(III)	423-100-1	-	Eye Dam. 1			Details
trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulphonate C.I. REACTIVE YELLOW 174; GIALLO REATTIVO 174; JAUNE REACTIF 174; REAKTIV GELB 174	402-170-5	106359-91-5	Skin Sens. 1			Details
trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate	440-480-2	341026-59-3	Eye Dam. 1; Skin Sens. 1			Details
trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate	430-280-3	844491-96-9	Skin Sens. 1			Details
trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate BLEU REACTIF CAC 10; DIOXAZINE MONCHLORTRIAZINE; FAT NO. 40 407; REACTIVE BLUE CAC 10	410-130-3	136248-03-8	Skin Sens. 1			Details

Juri 1 - 100 ta' 4,917 riżultati.

Export search results to:

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 03 Mejju 2024. Database contains 4917 unique substances/entries.

Footer Nav Items